Normal Risk Ovarian Screening Study: 21-Year Update.
Chae Young HanKaren H LuGwen CorriganAlexandra PerezSharlene D KohringJoseph CelestinoDeepak BediEnrique BediaTherese BeversDavid BorutaMatthew CarlsonLaura HolmanLeroy LeedsCara A MathewsGeorgia McCannRichard G MooreMatthew P SchlumbrechtBrian SlomovitzDan TobiasMarian Yvette Williams-BrownMichael W BeversJinsong LiuTerrie G GornetBeverly C HandyZhen LuJacob S BediaSteven J SkatesRobert C BastPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
While the NROSS trial was not powered to detect reduced mortality, the high specificity, PPV, and marked stage shift support further development of this strategy.